Alzheimer Drug Lecanemab Gains Traditional FDA Approval

被引：0

作者：

Harris, Emily

机构：

来源：

关键词：

D O I：

10.1001/jama.2023.12548

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：1

共 50 条

[1] Lecanemab Gains FDA Approval for Early Alzheimer Disease
Larkin, Howard D. D.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (05): : 363 - 363
[2] New Alzheimer Drug Gains Full Approval
Aschenbrenner, Diane S.
[J]. AMERICAN JOURNAL OF NURSING, 2023, 123 (10) : 23 - 23
[3] CMS Will Cover Alzheimer Drugs With Traditional FDA Approval
Harris, Emily
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (01): : 14 - 14
[4] FDA approves Alzheimer’s drug lecanemab amid safety concerns
Sara Reardon
[J]. Nature, 2023, 613 : 227 - 228
[5] FDA approves Alzheimer's drug lecanemab amid safety concerns
Reardon, Sara
[J]. NATURE, 2023, 613 (7943) : 227 - 228
[6] Alzheimer's disease: Lecanemab gets full FDA approval and black box safety warning
Mahase, Elisabeth
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 382 : p1580
[7] Spectrascience gains FDA approval
不详
[J]. JOURNAL OF CLINICAL LASER MEDICINE & SURGERY, 2002, 20 (06): : 346 - 346
[8] Contrave gains FDA approval
Idris, Iskandar
[J]. DIABETES OBESITY & METABOLISM, 2011, 13 (03): : 287 - 287
[9] GE salmon gains FDA approval
Cima, Greg
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2016, 248 (01): : 25 - 25
[10] TREATMENT FOR IMPOTENCE GAINS FDA APPROVAL
不详
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (19) : 2078 - 2079